GLP-1 medication list and interaction questions before your visit

Bring the medication list before the sales pitch

FDA says a medication list helps health care professionals understand a person's current health and reduce medication errors and adverse drug interactions. For GLP-1 care, that list should be ready before you rely on a clinic's price, timeline, or product promise. A clinician or pharmacist may need to review prescription medicines, over-the-counter medicines, vitamins, supplements, allergies, and recent medication changes before any treatment decision.

• List each medication name, dose, schedule, reason you take it, prescriber, and pharmacy when you can.
• Include over-the-counter medicines, vitamins, dietary supplements, herbal products, injections, patches, and recent short-term prescriptions.
• Include allergies, prior serious side effects, stopped medicines, and medications you take only as needed.
• Ask whether a licensed clinician or pharmacist reviews the list before payment, prescription, or shipment.

Ask about diabetes medicines and low-blood-sugar planning

Zepbound labeling says tirzepatide lowers blood glucose and that clinicians may need to consider changes to insulin or insulin secretagogues such as sulfonylureas to reduce hypoglycemia risk. Wegovy labeling also discusses hypoglycemia risk in people with type 2 diabetes when used with insulin or insulin secretagogues. Do not adjust these medicines yourself; use the visit to ask who coordinates glucose monitoring, medication changes, and urgent symptoms.

• Tell the clinician about insulin, sulfonylureas, other diabetes medicines, glucose monitors, and recent low-blood-sugar episodes.
• Ask whether your diabetes clinician, primary care clinician, or endocrinologist needs to coordinate care.
• Ask who gives written instructions if glucose readings change after starting or changing treatment.
• Ask what symptoms require local medical care instead of waiting for a portal reply.

Review oral medicines and timing-sensitive products

Zepbound prescribing information says tirzepatide delays gastric emptying and has the potential to affect absorption of oral medications. The label highlights oral hormonal contraceptives specifically, and MedlinePlus also tells patients to discuss medicines and supplements with clinicians. A provider should not turn that into a generic warning and move on; ask which of your oral medicines are timing-sensitive and who decides whether another prescriber should be involved.

• Ask whether any oral medicine on your list needs special timing, monitoring, or prescriber coordination.
• Ask specifically about oral contraceptives if you use them or might use them.
• Ask how vomiting, diarrhea, missed doses, or refill delays should be handled for other medicines you rely on.
• Ask whether the clinic communicates with your pharmacist or expects you to manage medication questions alone.

Treat supplements as part of the medication conversation

CDC, AHRQ, FDA, and MedlinePlus all advise people to include vitamins, supplements, herbs, and other nonprescription products in medication-safety conversations. Supplements can be easy to forget because they may not appear in pharmacy records, but they still matter for a clinician's review. The safest intake form asks for them directly and gives you room to add products that do not fit a standard drug-name field.

• List vitamins, minerals, herbal products, protein or weight-loss products, digestive aids, and products used only occasionally.
• Include brand names, active ingredients if known, and how often you actually take each product.
• Ask whether any supplement should be paused, continued, or reviewed by another clinician; do not decide based on this guide.
• Be cautious if a GLP-1 program sells supplements while also minimizing interaction or side-effect questions.

Share pharmacy and sourcing details, not just drug names

For GLP-1 care, medication safety also depends on the source. Tell the clinician where current prescriptions are filled, whether you use mail order or specialty pharmacies, whether an online program previously shipped medication, and whether any product was compounded or bought outside a state-licensed pharmacy path. FDA BeSafeRx advises consumers to use state-licensed pharmacy checks when buying prescription medicine online.

• Ask for the dispensing pharmacy name, state license path, pharmacist contact route, and prescription requirement.
• Ask whether the clinic can review pharmacy labels, medication guides, lot numbers, or prior fill history when relevant.
• Ask how medication-quality concerns, wrong product questions, and suspected adverse events are reported.
• Avoid offers that hide the pharmacy name, skip prescriptions, or treat research-only products as patient medication.

Keep the list current after the appointment

A medication list loses value if it freezes on intake day. Update it when another clinician changes a dose, a pharmacy substitution occurs, a supplement is added, pregnancy plans change, side effects appear, a procedure is scheduled, or insurance forces a product change. Ask the GLP-1 provider how updates are reviewed and whether changes trigger a clinician message, pharmacist review, local-care referral, or pause in fulfillment.

• Ask where to upload an updated medication list and whether the update becomes part of your record.
• Ask who reviews medication changes between visits and how quickly they respond.
• Ask whether the clinic keeps records accessible after cancellation or transfer.
• Keep your own copy so switching providers, appeals, travel, or emergency care does not depend on one portal.

What original data would make this decision easier

The strongest future version of this guide would compare provider medication-reconciliation workflows, pharmacist involvement, oral-contraceptive counseling language, diabetes-medication coordination policies, pharmacy partner disclosures, supplement-review boundaries, and update turnaround times. Until that data exists, treat medication-list review as a key provider-verification question.